Sort
30,917 grants matching “tumor microenvironment”
Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform
$1,134,487Ian Paul Winters · D2g Oncology, Inc. · R44 · FY2020 · CA
Tumor-Stroma Interacions in the Tumor Microenvironment
$1,134,010Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2010 · CA
Effect of Tumors on the Skeleton
$1,133,920Gregory R Mundy · Vanderbilt University · P01 · FY2008 · CA
Time Domian Electron Paramagnetic Resonance Imaging
$1,133,624Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A novel and effective immunotherapeutic approach for tumors with a low mutational load and few tumor-infiltrating lymphocytes, such as ovarian cancer
$1,133,263Jennifer June Sessions · Cynvec, Llc · R44 · FY2021 · CA
Nuclear Structure and Gene Expression
$1,132,152Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2014 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$1,131,849Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL
Emergency Myelopoiesis in the Control of Blood Production
$1,131,261Emmanuelle Passegue · Columbia University Health Sciences · R35 · FY2024 · HL
Effect of Tumors on the Skeleton
$1,130,748Gregory R Mundy · Vanderbilt University · P01 · FY2006 · CA
Effect of Tumors on the Skeleton
$1,130,480Gregory R Mundy · Vanderbilt University · P01 · FY2007 · CA
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment
$1,130,293Jyothi Rengarajan · Emory University · R01 · FY2024 · AI
Stromal Regulation of Bone Metastasis
$1,129,443Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA
Targeting the fibroblast-immune cell crosstalk to relieve immune suppression in the pancreatic cancer microenvironment
$1,128,458Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
$1,128,123William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
MOLECULAR ONCOLOGY PROGRAM PROJECT
$1,128,099University Of South Florida · P01 · FY2001 · CA
Mutographs differentiating the inheritance and temporal onset of multiple myeloma
$1,127,014Gareth John Morgan · New York University School Of Medicine · R01 · FY2025 · CA
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
$1,125,311Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2018 · CA
Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry
$1,124,755Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
Mechanism of action and therapeutic utility of immunostimulatory CpG oligonucleo
$1,124,689Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,124,257Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
NOX family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,123,750Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,122,823Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2023 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,122,822Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2022 · CA
Data Processing, Analysis, and Modeling Unit
$1,122,731Marc Elliott Lenburg · Boston University Medical Campus · U2C · FY2018 · CA
Tumor Microenvironment Interactions in Brain Tumors
$1,122,151Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2008 · CA